The Limits of Science for Policy

"If centuries are to be burdened with names, our own may bear the title of the century of science," write David Collingridge and Colin Reeve in their book Science Speaks to Power: The Role of Experts in Policymaking (Frances Pinter Publishers Ltd., 1986). As science and technology become increasingly important in issues of broad social import, how can science best inform the policymaking process? Historians and sociologists of science debate the merits of new agencies like the Science Policy Sup

Written byDavid Collingridge
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

For example, the great success of the chemical industry since the Second World War has necessitated the control of many hundreds of potentially hazardous substances in the workplace and in the general environment; the growth in pharmaceutical products has required similar intensive regulation. During this period, concern for the environment has grown, adding to the technical nature of much policy-making. The assumption throughout the literature is that there are very special new problems caused by the need for policy-makers to consider such increasingly technical issues.

But perhaps the problem is one of perception more than of reality. After all, what is the difference between settling a dispute over the control of an industrial chemical (where the workers appeal to scraps of scientific evidence supporting their view that it is poisonous, while management denies it) and making policy on a matter far removed from science—say, subsidies for farmers? Farmers will support ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies